Literature DB >> 15239289

Benefits of a dedicated cystic fibrosis pharmacist.

J Redfern1, A K Webb.   

Abstract

Entities:  

Mesh:

Year:  2004        PMID: 15239289      PMCID: PMC1308794     

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   5.344


× No keyword cloud information.
  1 in total

1.  Annual review hospital visits for patients with cystic fibrosis.

Authors:  J M Long; J Fauset-Jones; M J Dixon; D Worthington-Riley; V Sharma; L Patel; T J David
Journal:  J R Soc Med       Date:  2001       Impact factor: 18.000

  1 in total
  5 in total

1.  [Not Available].

Authors:  Aurélie Guérin; Elaine Caron; Johann-François Ouellette Frève; Denis Lebel; Jean-François Bussières
Journal:  Can J Hosp Pharm       Date:  2014-05

2.  Using A Work System Framework to Investigate Pharmacists' Roles in Cystic Fibrosis Management.

Authors:  Olufunmilola Abraham; Megan Buechel; Sommer Gay; Lisa Szela; Catherine A Decker; Andrew T Braun
Journal:  J Pediatr Pharmacol Ther       Date:  2022-03-21

Review 3.  European Cystic Fibrosis Society Standards of Care: Framework for the Cystic Fibrosis Centre.

Authors:  Steven Conway; Ian M Balfour-Lynn; Karleen De Rijcke; Pavel Drevinek; Juliet Foweraker; Trudy Havermans; Harry Heijerman; Louise Lannefors; Anders Lindblad; Milan Macek; Sue Madge; Maeve Moran; Lisa Morrison; Alison Morton; Jacquelien Noordhoek; Dorota Sands; Anneke Vertommen; Daniel Peckham
Journal:  J Cyst Fibros       Date:  2014-05       Impact factor: 5.482

Review 4.  Real-World Safety of CFTR Modulators in the Treatment of Cystic Fibrosis: A Systematic Review.

Authors:  Renée V E Dagenais; Victoria C H Su; Bradley S Quon
Journal:  J Clin Med       Date:  2020-12-23       Impact factor: 4.241

5.  Virtual medication tours with a pharmacist as part of a cystic fibrosis telehealth visit.

Authors:  Nicole Warda; Shannon M Rotolo
Journal:  J Am Pharm Assoc (2003)       Date:  2021-04-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.